Abstract:Objective To evaluate pharmacodynamics of prepared long-circulating superparamagnetic iron oxide (SPIO) liposomes. Methods Control and experimental groups were established after adding SPIO or long-circulating SPIO liposomes as agents. (1)Macrophages experiment in vitro: the RAW 264.7 macrophage cell strains were recovered, cultured and seeded in the culture plate at a density of 2.5×105 cells/well until they reached 80%-90% confluence. The intracellular Fe uptake of control and experimental group cells were quantified by Ferrozine assay after incubation with different concentrations of drugs. Factorial design analysis of variance was used as statistics method. Prussian blue staining method was used to detect staining of experimental cells.(2)Drug biodistribution in mice: C57BL/6J(n=6) were classified into blank control group (n=2), control group(n=2) and experimental group(n=2).Saline, SPIO and long circulating SPIO were injected via the tail vein in the blank control group, control group and experimental group respectively. Then distribution of drugs in the body was observed by pathological examination.(3) MR imaging of tumor-bearing nude mice: 20 BALB/c nude mice bearing lung cancer models were established and classified into control group and experimental group. After administration of drugs, all animals underwent MR scanning. Signal intensities of livers and tumors were measured, SNR-time dynamic curves were drew. Covariance analysis was used to compare post-enhanced SNR at the 12th hour. (4)Cytotoxicity studies (MTT): cytotoxicity of both drugs on human liver cell line HL-7702 was studied, and statistically analyzed using factorial design analysis of variance. Results (1) Macrophages experiment in vitro: The nanoparticle uptake by macrophage cells evaluated by ferrozine assay showed the uptake of blank SPIO was higher than long-circulating SPIO liposomes. Compared with the blank control group, there was strong blue staining in the macrophages with Prussian staining in the control group and little blue staining in the experimental group. (2) Drug biodistribution in mice: for blue stained cells composed of iron particles, the amounts in the liver, spleen, lung, kidney of the control group were more than those in the experimental group. (3) MR imaging of tumor-bearing nude mice: the non-enhanced SNR of livers and tumors in the control group and experimental group were 31.47 ± 0.56, 30.89 ± 1.41, 58.41 ± 0.61, 58.44 ± 1.08, respectively. After injecting of contrast agents, SNR of livers and tumors in the control group and experimental group were 17.00 ± 0.96, 22.29 ± 0.73, 58.50 ± 0.63, 52.47 ± 1.18, respectively. The covariance analysis showed that SNR of the livers in the control group after 12 hours was significantly lower than the experimental group (F=167.022, P=0.000); while the SNR of the tumors in the experimental group was significantly lower than the control group (F=266.106, P=0.000).(4) Cytotoxicity of nanoparticles by MTT method: the viability of HL-7702 cells tend to decrease with the increase of Fe concentration. Cytotoxicity in the long-circulating SPIO liposomes was lower than the SPIO(F=2256.204,P=0.000). Conclusions Long-circulating SPIO liposomes we prepared reveal suitable sizes, even distribution, and good anti-macrophage ability in vitro and in vivo. They have long circulation characteristic and T2 negative enhancement effect in the transplanted lung cancers, while they still maintain low cytotoxicity.

Initial preparation and physico-chemical properties of long-circulating superparamagnetic iron oxide liposome nanoparticles

The in vitro and in vivo experimental study of long-circulating superparamagnetic iron oxide liposome nanoparticles as novel MR contrast agent

Superparamagnetic Iron Oxide Nanoparticles: Key Physicochemical Properties and Biomedical Applications

Preparation and in vitro evaluation of PEG-coated superparamagnetic iron oxide nanoparticles

Biocompatible Low-Retention Superparamagnetic Iron Oxide Nanoclusters As Contrast Agents for Magnetic Resonance Imaging of Liver Tumor

Preparation of Superparamagnetic Iron Oxide and Determination of Their Dextran

Amphiphilic dextran/magnetite nanocomposites as magnetic resonance imaging probes

Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI

Polymer-brush-afforded SPIO Nanoparticles Show a Unique Biodistribution and MR Imaging Contrast in Mouse Organs

A T1/T2 dual functional iron oxide MRI contrast agent with super stability and low hypersensitivity benefited by ultrahigh carboxyl group density

Magnetic resonance signal detection of superparamagnetic iron oxide nanoparticles and its biological effects on endothelial cells]

Study of dextran-coated superparamagnetic iron oxides nanoparticles as MRI constrast agent

Preparation and MRI Characteristics of Supraparamagnetic Ironic Oxide-Loaded Polymeric Nano-Vesicles

Self-Assembled Superparamagnetic Nanoparticles As Mri Contrast Agents - A Review

Superparamagnetic iron oxide and 1, 1′-dioctadecyl-3,3,3′, 3′-tetramethylindocarbocyanine perchlorate loaded polymer microspheres for macrophages MR imaging

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.

One-pot Facile Synthesis of PEGylated Superparamagnetic Iron Oxide Nanoparticles for MRI Contrast Enhancement.

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast<i>T</i><sub>1</sub>- and<i>T</i><sub>2</sub>-weighted magnetic resonance imaging

2, 3-Dimercaptosuccinic Acid-Modified Iron Oxide Clusters for Magnetic Resonance Imaging

Synthesis and Application of Magnetic Iron Oxide Nanoparticles as High Efficiency Magnetic Resonance Imaging Contrast Agent

Transferrin-Conjugated Superparamagnetic Iron Oxide Nanoparticles As in Vivo Magnetic Resonance Imaging Contrast Agents